![]() | This template does not require a rating on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
This template survived a discussion at TfD. Several editors said it should be 'flattened' in some way. The debate can be found here. - Splash talk 19:46, 20 November 2005 (UTC)
Should viricides be added to this template? -- stillnotelf has a talk page 02:00, 1 February 2006 (UTC)
I propose this template be split into HIV and non-HIV antivirals. It's getting very big. User:Hopping T 04:09, 30 November 2007 (UTC)
NOV-002 is currently in Phase III under Fast Track Special Protocol Assessment. why are you saying Never to Phase III?
http://clinicaltrials.gov/show/NCT00347412
Fully enrolled Phase III trial link supplied.
Bixbyte ( talk) 16:27, 24 October 2009 (UTC)Bixbyte
![]() | This template does not require a rating on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
This template survived a discussion at TfD. Several editors said it should be 'flattened' in some way. The debate can be found here. - Splash talk 19:46, 20 November 2005 (UTC)
Should viricides be added to this template? -- stillnotelf has a talk page 02:00, 1 February 2006 (UTC)
I propose this template be split into HIV and non-HIV antivirals. It's getting very big. User:Hopping T 04:09, 30 November 2007 (UTC)
NOV-002 is currently in Phase III under Fast Track Special Protocol Assessment. why are you saying Never to Phase III?
http://clinicaltrials.gov/show/NCT00347412
Fully enrolled Phase III trial link supplied.
Bixbyte ( talk) 16:27, 24 October 2009 (UTC)Bixbyte